Raymond James Financial Inc Organogenesis Holdings Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 420,321 shares of ORGO stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
420,321Holding current value
$1.21 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORGO
# of Institutions
142Shares Held
64.5MCall Options Held
15.3KPut Options Held
925-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$35.8 Million4.46% of portfolio
-
Morgan Stanley New York, NY12.1MShares$34.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$14.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$12.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.1MShares$8.9 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $376M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...